The promotion effect of anorectic drugs on aflatoxin B1-induced hepatic preneoplastic foci

Carcinogenesis

Volumn 20, Issue 9, 1999, Pages 1793-1799

  Lin, Xu ^b   Levitsky, David A ^a   King, John M ^a   Campbell, T Colin ^a  

^a Department of Obstetrics Gynecology   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; AMPHETAMINE; ANOREXIGENIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FENFLURAMINE; FLUOXETINE; GAMMA GLUTAMYLTRANSFERASE; LIOTHYRONINE; SEROTONIN AGONIST; THYROXINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY MASS; CONTROLLED STUDY; DIET; FOOD INTAKE; GROWTH RATE; HISTOPATHOLOGY; LIOTHYRONINE BLOOD LEVEL; LIVER DISEASE; LIVER TUMOR; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT; THYROXINE BLOOD LEVEL; TUMOR PROMOTION; WEIGHT GAIN;

ADIPOSE TISSUE, BROWN; AFLATOXIN B1; AMPHETAMINE; ANIMALS; APPETITE DEPRESSANTS; BIOLOGICAL MARKERS; BODY TEMPERATURE REGULATION; CARCINOGENS; COCARCINOGENESIS; DOPAMINE; DRUG SYNERGISM; EATING; ENERGY METABOLISM; FENFLURAMINE; FLUOXETINE; GAMMA-GLUTAMYLTRANSFERASE; GROWTH DISORDERS; HYPOTHYROIDISM; LIVER DISEASES; LIVER NEOPLASMS, EXPERIMENTAL; MALE; ORGAN SIZE; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; WEIGHT LOSS;

EID: 0032861325     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.9.1793     Document Type: Article

References (64)

1. + hepatic foci in F344 rats. Int. J. Obes. Relat. Metab. Disord., 17, 215-221.
2. 1-induced preneoplaslic foci in rat liver. Nutr. Cancer, 16, 31-41.
3. + foci indicate neoplastic potential. Carcinogenesis, 13, 1607-1613.
4. Krieger, E. (1988) Increased voluntary exercise by Fisher 344 rats fed low protein diets. Undergraduate thesis, Cornell University, Ithaca, NY.
5. Silverstone, T. (1992) Appetite suppressants. A review. Drugs, 43, 820-836.
6. Carruba, M.O. and Mantegazza, P. (1981) Drugs with effects on food intake and energy expenditure. In Cioffi, L.A., James, W.P.T. and Van Itallie, T.B. (eds) The Body Weight Regulation System: Normal and Disturbed Mechanisms. Raven Press, New York, NY, pp. 279-287.
7. Silverstone, T. and Goodall, E. (1992) Centrally acting anorectic drugs: a clinical perspective. Am. J. Clin. Nutr., 55, 211S-214S.
8. Voelker, R. (1994) Obesity drug renews toxicity debate [news]. J. Am. Med. Assoc., 272, 1087-1088.
9. Guy-Grand, B. (1992) Clinical studies with d-fenfluramine. Am. J. Clin. Nutr., 55, 173S-176S.
10. Benfield, P., Heel, R.C. and Lewis, S.P. (1986) Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs, 32, 481-508.
11. Dexfenfluramine Hydrochloride (1998) PDR Generics, 4th Edn. Medical Economics Co., Montvale, NJ, pp. 813-817.
12. Bendele, R.A., Adams, E.R., Hoffman, W.P., Gries, C.L. and Morton, D.M. (1992) Carcinogenicity studies of fluoxetine hydrochloride in rats and mice. Cancer Res., 52, 6931-6935.
13. Brandes, L.J., Arron, RJ., Bogdanovic, R.P., Tong, J., Zaborniak, C.L., Hogg, G.R., Warrington, R.C., Fang, W. and LaBella, F.S. (1992) Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res., 52, 3796-3800.
14. Fenfluramine Hydrochloride (1998) PDR Generics, 4th Edn. Medical Economics Co., Montvale, NJ, pp. 1168-1170.
15. Dunnick, J.K. and Eustis, S.L. (1991) Decreases in spontaneous tumors in rats and mice after treatment with amphetamine. Toxicology, 67, 325-332.
16. Rothwell, N.J., Stock, M.J. and Wyllie, M.G. (1981) Sympathetic mechanisms in diet-induced thermogenesis: modification by ciclazindol and anorectic drugs. Br. J. Pharmacol., 74, 539-546.
17. Rutenburg, AM., Kim, H., Fischbein, J.W., Hanker, J.S., Wasserkrug, H.L. and Seligman, A.M. (1969) Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity. J. Histochem. Cytochem., 17, 517-526.
18. Campbell, H.A., Pitot, H.C., Potter, V.R. and Laishes, B.A. (1982) Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver. Cancer Res., 42, 465-472.
19. AOAC (1970) A.O.A.C. Methods, XI Edn. AOAC, Arlington, VA.
20. AOAC (1980) Official Methods of Analysis, 13th Edn. AOAC, Arlington, VA, s7.062, 24.005.
21. AOCS (1983) Official and Tentative Methods of the American Oil Chemists Society, 3rd Edn. AOCS, Chicago, IL, method Ba-38.
22. Thonney, M.L., Oberbauer, A.M., Duhaime, D.J., Jenkins, T.C. and Firth, N.L. (1984) Empty body component gain of rats grown at different rates to a range of final weights. J. Nutr., 114, 1777-1786.
23. Bell, G.E. and Stern, J.S. (1977) Evaluation of body composition of young obese and lean Zucker rats. Growth, 41, 63-80.
24. Lin, X. (1998) Potential tumor promotion effects of anorectic drugs. Ph.D. dissertation, Cornell University, Ithaca, NY.
25. Levitsky, D.A., Schuster, J.A., Stallone, D. and Strupp, B.J. (1986) Modulation of the thermic effect of food by fenfluramine. Int. J. Obes., 10, 169-173.
26. Rothwell, N.J. and Le Feuvre, R.A. (1992) Thermogenesis, brown adipose tissue and dexfenfluramine in animal studies. Int. J. Obes. Relat. Metab. Disord., 16, S67-S71.
27. Scheen, A.J. and Lefebvre, P.J. (1993) Pharmacological treatment of the obese diabetic patient. Diabetes Metab., 19, 547-559.
28. Rothwell, N.J. and Stock, M.J. (1987) Effect of diet and fenfluramine on thermogenesis in the rat: possible involvement of serotonergic mechanisms. Int. J. Obes., 11, 319-324.
29. Ma, S.W. and Preston, E. (1992) Disparate effects of fenfluramine on thermogenesis in brown adipose tissue in the rat. Can. J. Physiol. Pharmacol., 70, 214-218.
30. Le Feuvre, R.A., Aisenthal, L. and Rothwell, N.J. (1991) Involvement of corticotrophin releasing factor (CRF) in the thermogenic and anorexic actions of serotonin (5-HT) and related compounds. Brain Res., 555, 245-250.
31. Levy, A.D, and Ellison, G.D. (1987) Interaction between chronic amphetamine and neuroleptic treatments on oral behavior in rats. Psychopharmacol. (Berl.), 93, 218-222.
32. Craddock, D. (1976) Anorectic drugs: use in general practice. Drugs, 11, 378-393.
33. Garattini, S., Bizzi, A., Caccia, S. and Mennini, T. (1992) Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline. Int. J. Obes. Relat. Metab. Disord., 16, S43-S50.
34. Glauert, H.P., Schwarz, M. and Pitot, H.C. (1986) The phenotypic stability of altered hepatic foci: effect of the short-term withdrawal of phenobarbital and of the long-term feeding of purified diets after the withdrawal of phenobarbital. Carcinogenesis, 7, 117-121.
35. Tatematsu, M., Mera, Y., Inoue, T., Satoh, K., Sato, K. and Ito, N. (1988) Stable phenotypic expression of glutathione S-transferase placental type and unstable phenotypic expression of gamma-glutamyltransferase in rat liver preneoplastic and neoplastic lesions. Carcinogenesis, 9, 215-220.
36. Youngman, L.D. and Campbell, T,C. (1992) The sustained development of preneoplastic lesions depends on high protein intake. Nutr. Cancer, 18, 131-142.
37. Bursch, W., Lauer, B., Timmermann-Trosiener, I., Barthel, G., Schuppler, J. and Schulte-Hermann, R. (1984) Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 5, 453-458.
38. Farber, E. and Sarma, D.S. (1986) Chemical carcinogenesis: the liver as a model. Pathol. Immunopathol. Res., 5, 1-28.
39. Tannenbaum, A. (1942) The genesis and growth of tumors II. Effects of caloric restriction per se. Cancer Res., 2, 460-467.
40. Tannenbaum, A. and Silverstone, H. (1957). Nutrition and the genesis of tumors. In Raven, R.W. (ed.) Cancer, Butterworth & Co., London, UK, Vol. 1, pp. 306-334.
41. Kritchevsky, D., Weber, M.M. and Klurfeld, D.M. (1984) Dietary fat versus caloric content in initiation and promotion of 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats. Cancer Res., 44, 3174-3177.
42. Klurfeld, D.M., Weber, M.M. and Kritchevsky, D. (1987) Inhibition of chemically induced mammary and colon tumor promotion by caloric restriction in rats fed increased dietary fat. Cancer Res., 47, 2759-2762.
43. Lagopoulos, L., Sunahara, G.I., Wurzner, H., Fliesen, J. and Stalder, R. (1991) The correlation of body growth with diethylnitrosamine-induced hepatocarcinogenesis in relation to serum insulin and somatomedin-C. Carcinogenesis, 12, 211-215.
44. Sugie, S., Reddy, B.S., Lowenfels, A., Tanaka, T. and Mori, H. (1992) Effect of voluntary exercise on azoxymethane-induced hepatocarcinogenesis in male F344 rats. Cancer Lett., 63, 67-72.
45. Herren, S.L. and Pereira, M.A. (1983) Tumor promotion in rat liver. Environ. Health Perspect., 50, 123-129.
46. Russell, JJ., Staffeldt, E.F., Wright, B.J., Prapuolenis, A., Carnes, B.A. and Peraino, C. (1987) Effects of rat strain, diet composition, and phenobarbital on hepatic gamma-glutamyl transpeptidase histochemistry and on the induction of altered hepatocyte foci and hepatic tumors by diethylnitrosamine. Cancer Res., 47, 1130-1134.
47. Yager, J.D., Roebuck, B.D., Paluszcyk, T.L. and Memoli, V.A. (1986) Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. Carcinogenesis, 7, 2007-2014.
48. Ghoshal, A.K., Rushmore, T.H. and Farber, E. (1987) Initiation of carcinogenesis by a dietary deficiency of choline in the absence of added carcinogens. Cancer Lett., 36, 289-296.
49. Youngman, L.D. and Campbell, T.C. (1992) Attenuation of preneoplastic lesion development by dietary protein intervention: apparent persistence and regression. Cancer Lett., 66, 165-174.
50. Kitagawa, T., Imai, F. and Sato, K (1980) Re-elevation of gamma-glutamyl transpeptidase activity in periportal hepatocytes of rats with age. Gann, 71, 362-366.
51. Sulakhe, S.J. and Lautt, W.W. (1987) A characterization of gamma-glutamyltranspeptidase in normal, perinatal, premalignant and malignant rat liver. Int. J. Biochem., 19, 23-32.
52. Pitot, H.C., Glauert, H.P. and Hanigan, M. (1985) The significance of selected biochemical markers in the characterization of putative initiated cell populations in rodent liver. Cancer Lett., 29, 1-14.
53. Schulte-Hermann, R., Schuppler, J., Timmermann-Trosiener, I., Ohde, G., Bursch, W. and Berger, H. (1983) The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver. Environ. Health Perspect., 50, 185-194.
54. Huang, H.H., Hawrylewicz, E.J., Kissane, J.Q. and Drab, A. (1982) Effect of protein diet on release of prolactin and ovarian steroids in female rats. Nutr. Rep. Int., 26, 807-820.
55. Tutton, P.J. and Barkla, D.H. (1982) Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas. Br. J. Cancer, 46, 260-265.
56. + NK cells, accessory monocytes, and 5-HT1A receptors. Cell Immunol., 127, 199-214.
57. Guyton, A.C. (1991) Textbook of Medical Physiology, 8th Edn. W.S. Saunders Co., Philadelphia, PA.
58. Garrison, J.C. (1990) Histamine, bradykinin, 5-hydroxytryptamine, and their antagonists. In Gilman, A.G., Ral, T.W., Nies, A.S. and Taylor, P. (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics. Pergamon Press, New York, NY, pp. 575-599.
59. Donnelly, M., Rapoport, J.L., Potter, W.Z., Oliver, J., Keysor, C.S. and Murphy, D.L. (1989) Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings. Arch. Gen. Psychiat., 46, 205-212.
60. Abdul, M., Logothetis, C.J. and Hoosein, N.M. (1995) Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines. J. Urol., 154, 247-250.
61. Lemberger, L., Bergstrom, R.F., Wolen, R.L., Farid, N.A., Enas, G.G. and Aronoff, G.R. (1985) Fluoxetine: clinical pharmacology and physiologic disposition. J. Clin. Psychiat., 46, 14-19.
62. Lemberger, L., Rowe, H., Carmichael, R., Crabtree, R., Horng, J.S., Bymaster, F. and Wong, D. (1978) Fluoxetine, a selective serotonin uptake inhibitor. Clin. Pharmacol. Ther., 23, 421-429.
63. Nielsen, L.H., Knudsen, F. and Olesen, A.S. (1990) [Use of ketanserin in anesthesia. A selective S2 serotonin receptor antagonist]. Ugeskr. Laeger, 152, 1653-1655.
64. Skolnik, G., Bagge, U., Dahlstrom, A. and Ahlman, H. (1984) The importance of 5-HT for tumor cell lodgement in the liver. Int. J. Cancer, 33, 519-523.